JP2012507542A5 - - Google Patents

Download PDF

Info

Publication number
JP2012507542A5
JP2012507542A5 JP2011534668A JP2011534668A JP2012507542A5 JP 2012507542 A5 JP2012507542 A5 JP 2012507542A5 JP 2011534668 A JP2011534668 A JP 2011534668A JP 2011534668 A JP2011534668 A JP 2011534668A JP 2012507542 A5 JP2012507542 A5 JP 2012507542A5
Authority
JP
Japan
Prior art keywords
phenyl
benzoic acid
piperazin
acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011534668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012507542A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/062154 external-priority patent/WO2010056506A1/en
Publication of JP2012507542A publication Critical patent/JP2012507542A/ja
Publication of JP2012507542A5 publication Critical patent/JP2012507542A5/ja
Withdrawn legal-status Critical Current

Links

JP2011534668A 2008-10-30 2009-10-27 ジアシルグリセロールアシルトランスフェラーゼ阻害剤 Withdrawn JP2012507542A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10958908P 2008-10-30 2008-10-30
US61/109,589 2008-10-30
PCT/US2009/062154 WO2010056506A1 (en) 2008-10-30 2009-10-27 Diacylglycerol aclytransferase inhibitors

Publications (2)

Publication Number Publication Date
JP2012507542A JP2012507542A (ja) 2012-03-29
JP2012507542A5 true JP2012507542A5 (https=) 2012-12-20

Family

ID=42132236

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011534668A Withdrawn JP2012507542A (ja) 2008-10-30 2009-10-27 ジアシルグリセロールアシルトランスフェラーゼ阻害剤

Country Status (8)

Country Link
US (1) US8324385B2 (https=)
EP (1) EP2350311B1 (https=)
JP (1) JP2012507542A (https=)
CN (1) CN102203280A (https=)
AU (1) AU2009314358B2 (https=)
CA (1) CA2741601A1 (https=)
IL (1) IL212496A0 (https=)
WO (1) WO2010056506A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8211884B2 (en) * 2008-08-06 2012-07-03 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
JP2011057661A (ja) * 2009-08-14 2011-03-24 Bayer Cropscience Ag 殺虫性カルボキサミド類
KR101609856B1 (ko) * 2010-03-17 2016-04-07 타이벡스 세라피틱스 코포레이션 Ｈｅｃ１ 활성의 조절인자 및 이의 방법
FR2963005B1 (fr) * 2010-07-23 2012-08-17 Sanofi Aventis Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique
CN101993415B (zh) * 2010-09-15 2013-08-14 北京韩美药品有限公司 作为Hedgehog通路抑制剂的化合物以及包含该化合物的药物组合物及其应用
ES2736999T3 (es) 2011-11-21 2020-01-09 Taivex Therapeutics Corp Biomarcadores para cánceres que responden a moduladores de la actividad de Hec1
US11071736B2 (en) 2011-11-21 2021-07-27 Taivex Therapeutics Corporation Modulators of HEC1 activity and methods therefor
TWI640519B (zh) 2011-11-29 2018-11-11 泰緯生命科技股份有限公司 Ｈｅｃ１活性調控因子及其調節方法
JP6129199B2 (ja) * 2011-12-02 2017-05-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ピペリジン誘導体、その医薬組成物及び使用
US9796729B2 (en) 2012-11-23 2017-10-24 Glaxosmithkline Llc Compounds as diacylglycerol acyltransferase inhibitors
BR112015011982A8 (pt) * 2012-11-23 2019-10-08 Glaxosmithkline Llc compostos inibidores de diacilglicerol aciltransferase, composição farmacêutica compreendendo estes e usos destes
WO2014081996A1 (en) * 2012-11-23 2014-05-30 Glaxosmithkline Llc Novel compounds as diacylglycerol acyltransferase inhibitors
SG11201509070YA (en) * 2013-05-29 2015-12-30 Bristol Myers Squibb Co Dihydropyridinone mgat2 inhibitors
CA2920815C (en) * 2013-08-14 2021-09-21 Kalvista Pharmaceuticals Limited Inhibitors of plasma kallikrein
TWI636047B (zh) 2013-08-14 2018-09-21 英商卡爾維斯塔製藥有限公司 雜環衍生物
LT3119757T (lt) * 2014-03-17 2018-07-10 Pfizer Inc. Diacilglicerolio aciltransferazės 2 inhibitoriai, skirti panaudoti metabolinių ir susijusių ligų gydyme
GB201421083D0 (en) 2014-11-27 2015-01-14 Kalvista Pharmaceuticals Ltd Enzyme inhibitors
GB201421085D0 (en) 2014-11-27 2015-01-14 Kalvista Pharmaceuticals Ltd New enzyme inhibitors
EP3227277B1 (en) * 2014-12-05 2020-02-05 Pulmocide Limited Antimycotic compound
US10865185B2 (en) 2015-08-21 2020-12-15 Srx Cardio, Llc Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity
US10821106B2 (en) 2015-08-21 2020-11-03 Srx Cardio, Llc Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity
HK1257102A1 (zh) 2015-08-21 2019-10-11 Portola Pharmaceuticals, Inc. 苯基哌嗪前蛋白转化酶枯草杆菌蛋白酶/kexin9型(pcsk9)调节剂及其应用
US20190119236A1 (en) 2016-02-23 2019-04-25 Portola Pharmaceuticals, Inc. Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
IL263235B (en) 2016-05-31 2022-07-01 Kalvista Pharmaceuticals Ltd History of pyrazoles as plasma kallikrein inhibitors
GB201609607D0 (en) 2016-06-01 2016-07-13 Kalvista Pharmaceuticals Ltd Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
GB201609603D0 (en) 2016-06-01 2016-07-13 Kalvista Pharmaceuticals Ltd Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide
GB201719881D0 (en) 2017-11-29 2018-01-10 Kalvista Pharmaceuticals Ltd Solid forms of plasma kallikrein inhibitor and salts thereof
HUE057912T2 (hu) 2017-11-29 2022-06-28 Kalvista Pharmaceuticals Ltd Plazma kallikrein inhibitort tartalmazó dózisformák
WO2021028645A1 (en) 2019-08-09 2021-02-18 Kalvista Pharmaceuticals Limited Plasma kallikrein inhibitors
PH12022551271A1 (en) * 2019-12-23 2023-11-29 Lg Chemical Ltd Novel amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof
CA3179059A1 (en) * 2020-06-09 2021-12-16 Anima Biotech Inc. Collagen 1 translation inhibitors and methods of use thereof
US12115154B2 (en) 2020-12-16 2024-10-15 Srx Cardio, Llc Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
AU2022214582C1 (en) * 2021-01-29 2025-02-27 Korea Research Institute Of Chemical Technology Benzothiazole and benzimidazole derivatives, pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition comprising same as active ingredient
WO2022222890A1 (en) * 2021-04-19 2022-10-27 Shanghai Yao Yuan Biotechnology Co., Ltd. Benzothiazole and quinoline derivatives for use in treating kawasaki disease

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250771A (en) * 1962-12-17 1966-05-10 Geigy Chem Corp 5-monocarbocyclic aryl-n-lower alkyl-2-pyrrolidine carboxylic acid, esters, amides and derivatives thereof
US3863007A (en) * 1971-05-21 1975-01-28 Jr Paul L Warner Sunscreening method containing 4-di (lower)alkylaminobenzamides
DE2337461A1 (de) * 1973-07-24 1975-02-06 Boehringer Mannheim Gmbh Neue indolderivate und verfahren zu deren herstellung
US4066654A (en) * 1975-04-16 1978-01-03 G. D. Searle & Co. 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives
EP0837052B1 (en) * 1995-06-21 2006-08-23 Shionogi & Co., Ltd. Bicyclic amino derivatives and pgd 2 antagonist containing the same
US6495558B1 (en) * 1999-01-22 2002-12-17 Amgen Inc. Kinase inhibitors
CN1230421C (zh) 1999-02-10 2005-12-07 三菱制药株式会社 酰胺化合物及其药物用途
US6756374B2 (en) * 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
HRP20040199A2 (en) 2001-08-31 2005-04-30 Aventis Pharma Deutschland Gmbh Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
GB0209715D0 (en) * 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
AU2003261935A1 (en) 2002-09-06 2004-03-29 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
KR100772297B1 (ko) * 2002-11-22 2007-11-02 니뽄 다바코 산교 가부시키가이샤 융합 비시클릭 질소-함유 헤테로사이클
DE10308353A1 (de) * 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7148246B2 (en) * 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
US6984652B2 (en) * 2003-09-05 2006-01-10 Warner-Lambert Company Llc Gyrase inhibitors
AR051596A1 (es) 2004-10-26 2007-01-24 Irm Llc Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
US7795283B2 (en) * 2004-12-14 2010-09-14 Astrazeneca Ab Oxadiazole derivative as DGAT inhibitors
KR100883694B1 (ko) * 2005-02-07 2009-02-12 에프. 호프만-라 로슈 아게 디아실글리세롤 아실트랜스퍼라제 억제제
EP1884513A4 (en) * 2005-05-23 2010-04-28 Japan Tobacco Inc PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME
KR20080015113A (ko) 2005-06-11 2008-02-18 아스트라제네카 아베 Ｄｇａｔ 억제제로서의 옥사디아졸 유도체
WO2007008541A2 (en) * 2005-07-08 2007-01-18 Kalypsys, Inc. Cellular cholesterol absorption modifiers
MX2008000966A (es) * 2005-07-19 2008-03-26 Merck & Co Inc Nuevos derivados de espirocromanona.
CA2630269C (en) * 2005-11-28 2011-07-05 F. Hoffmann-La Roche Ag Inhibitors of diacyglycerol acyltransferase (dgat)
GB0611507D0 (en) 2006-06-10 2006-07-19 Astrazeneca Ab Chemical compounds
WO2008098851A1 (en) 2007-02-14 2008-08-21 Basf Se Electroluminescent metal complex
US8115011B2 (en) * 2007-05-22 2012-02-14 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
US20090099201A1 (en) * 2007-05-22 2009-04-16 David Robert Bolin Diacylglycerol Acyltransferase Inhibitors
AU2008253118B2 (en) 2007-05-22 2013-11-21 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
US8153644B2 (en) * 2007-05-22 2012-04-10 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
US8058299B2 (en) * 2007-05-22 2011-11-15 Via Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
CA2695071A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of cns disorders
US8211884B2 (en) 2008-08-06 2012-07-03 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
WO2010065310A1 (en) 2008-12-03 2010-06-10 Via Pharmaceuticals, Inc Inhibitors of diacylglycerol acyltransferase
AU2009333333A1 (en) 2008-12-17 2011-06-30 Via Pharmaceuticals, Inc Inhibitors of diacylglycerol aclytransferase

Similar Documents

Publication Publication Date Title
JP2012507542A5 (https=)
JP5650233B2 (ja) 選択的スフィンゴシン−１−リン酸受容体変調因子および不斉合成方法
EP2350311B1 (en) Diacylglycerol acyltransferase inhibitors
JP2010539152A5 (https=)
JP5922027B2 (ja) 選択的複素環式スフィンゴシン−１−リン酸受容体変調因子
JP2010516742A5 (https=)
JP2010506825A5 (https=)
JP2007520471A5 (https=)
JP2012512252A5 (https=)
JP2005521741A5 (https=)
JP2012530765A5 (https=)
OA12346A (en) Carboxamide compounds and their use as antagonistsof a human 11 CBY receptor.
NZ627750A (en) Carbamate compounds and of making and using same
RU2012129737A (ru) Замещенные бензамидные производные
CA2515726A1 (en) Isoxazole compounds
WO2002098840A1 (en) Carboxylic acid derivative and medicine comprising salt or ester of the same
RU2006137272A (ru) Производные 2-фенилпропионовой кислоты и содержащие их фармацевтические композиции
JP2004518702A5 (https=)
NO155805C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
JP2004529174A5 (https=)
CA2581945A1 (en) Hexafluoroisopropanol substituted ether derivatives
MX2009000110A (es) Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor grp38.
BRPI0923380B8 (pt) Processo para preparação de compostos trans de n-{4-{2-[4-(2,3-diclorofenil)-piperazina-1-il]-etil}-ciclohexil}-carbamida e sais hidrocloretos dos mesmos
CA2504269A1 (en) Piperazinyl and diazapanyl benzamides and benzthioamides
JP2006510609A5 (https=)